SB268 Alabama 2020 Session

Summary

Primary Sponsor

Bobby D. SingletonSenator

Democrat

Session

Regular Session 2020

Title

Public health, Alabama Injection-Associated Infectious Disease Elimination Act. established

Summary

SB268 would let the state's largest county run injection-associated infectious disease elimination pilot programs with safety, education, treatment access, and immunity protections for participants and program staff.

What This Bill Does

The bill authorizes a local health authority in the most populous Alabama county to create up to five-year pilots to reduce HIV, HCV, and other infection risks from injection drug use. Programs must provide safe needle disposal, free needles and supplies (funded from non-state-supplied sources), overdose and disease education, naloxone access or referrals, and referrals for medical, mental health, and substance-use treatment, while keeping participants’ identities anonymous. It grants criminal and civil immunity to program participants and to certain staff/partners, and issues official certificate cards to participants to prove immunity; it also allows limited immunity for law enforcement under defined conditions. The State Board of Health would adopt operating rules, and annual reports with program metrics would be submitted to legislative health committees.

Who It Affects

• Group 1: Individuals who inject drugs in the eligible (most populous) county, who may enroll in the program, receive supplies and services, gain protection from certain criminal charges for program-related activity, and obtain education, referrals, and a certificate card.
• Group 2: Local health authorities and program staff/organizations operating the pilot (including partner clinics and providers), who can establish and run the program, receive immunity protections for program activities, must follow confidentiality rules and reporting requirements, and coordinate with law enforcement.

Key Provisions

• Authorizes a local health authority in the state's most populous county to establish injection-associated infectious disease elimination pilot programs for up to five years.
• Aims to reduce spread of HIV, HCV, and other injection-related diseases, reduce needle-stick injuries, and encourage treatment for substance use disorders.
• Programs must safely dispose of used needles, provide injection supplies at no cost (funds may not be used to buy supplies), offer educational materials, provide naloxone or referrals, conduct personal consultations, screen and treat infectious diseases, and maintain anonymous recordkeeping; require emergency care access and confidentiality compliance.
• Requires official certificate cards for participants and provides immunity from criminal liability for possession/use of program supplies; prescribes conditions for immunity including card presentation and activity within the program; extends limited civil immunity for certain law enforcement actions under defined circumstances.
• Immunity also extends to program staff, local health authority employees, and affiliated organizations; physicians are not liable when in compliance with the act and board rules.
• The State Board of Health will adopt rules governing program operations (counseling, referrals, dispensing needles).
• Requires annual reports to the Senate Healthcare Committee and House Health Committee detailing participants served, supplies dispensed/returned, naloxone distribution/referrals, and treatment and other service referrals.
• Effective date is the first day of the third month after passage/approval.

AI-generated summary using openai/gpt-5-nano on Feb 23, 2026. May contain errors — refer to the official bill text for accuracy.

Subjects

Health